tiprankstipranks
Trending News
More News >
Biocon Limited (IN:BIOCON)
:BIOCON
India Market
Advertisement

Biocon Limited (BIOCON) Stock Statistics & Valuation Metrics

Compare
5 Followers

Total Valuation

Biocon Limited has a market cap or net worth of ₹529.57B. The enterprise value is ₹672.37B.
Market Cap₹529.57B
Enterprise Value₹672.37B

Share Statistics

Biocon Limited has 1,336,963,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,336,963,600
Owned by Insiders
Owned by Institutions0.06%

Financial Efficiency

Biocon Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 9.93%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)9.93%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee9.23M
Profits Per Employee876.13K
Employee Count16,315
Asset Turnover0.26
Inventory Turnover1.13

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio46.9
PS Ratio0.00
PB Ratio2.17
Price to Fair Value1.63
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio1.77

Income Statement

In the last 12 months, Biocon Limited had revenue of 150.52B and earned 10.13B in profits. Earnings per share was 8.46.
Revenue150.52B
Gross Profit98.55B
Operating Income13.32B
Pretax Income18.87B
Net Income10.13B
EBITDA44.71B
Earnings Per Share (EPS)8.46

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Biocon Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.13%
Dividend Per Share₹0.5
Dividend Yield0.13%
Payout Ratio23.95%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.25
52-Week Price Change8.00%
50-Day Moving Average357.72
200-Day Moving Average348.13
Relative Strength Index (RSI)64.72
Average Volume (3m)213.36K

Important Dates

Biocon Limited upcoming earnings date is Aug 7, 2025, TBA (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateJul 04, 2025

Financial Position

Biocon Limited as a current ratio of 0.99, with Debt / Equity ratio of 84.84%
Current Ratio0.99
Quick Ratio0.67
Debt to Market Cap0.49
Net Debt to EBITDA3.62
Interest Coverage Ratio5.22

Taxes

In the past 12 months, Biocon Limited has paid 4.57B in taxes.
Income Tax4.57B
Effective Tax Rate0.15

Enterprise Valuation

Biocon Limited EV to EBITDA ratio is 11.39, with an EV/FCF ratio of 46.27.
EV to Sales3.21
EV to EBITDA11.39
EV to Free Cash Flow46.27
EV to Operating Cash Flow16.01

Balance Sheet

Biocon Limited has ₹50.23B in cash and marketable securities with ₹183.62B in debt, giving a net cash position of ₹133.39B billion.
Cash & Marketable Securities₹50.23B
Total Debt₹183.62B
Net Cash₹133.39B
Net Cash Per Share₹99.77
Tangible Book Value Per Share-₹11.58

Margins

Gross margin is 58.39%, with operating margin of 34.45%, and net profit margin of 6.93%.
Gross Margin58.39%
Operating Margin34.45%
Pretax Margin10.34%
Net Profit Margin6.93%
EBITDA Margin28.14%
EBIT Margin16.94%

Analyst Forecast

The average price target for Biocon Limited is ₹390.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹390.00
Price Target Upside-1.02% Downside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast3.43%
EPS Growth Forecast-0.90%

Scores

Smart ScoreN/A
AI Score77
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis